Non-inferiority Trial of Dapaconazole Versus Ketoconazole
Status:
Completed
Trial end date:
2019-11-12
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to demonstrate that dapaconazole cream 2% (experimental
drug) is non-inferior to ketoconazole cream 2% (Nizoral® - active comparator) for the
treatment of dermatological lesions of Tinea pedis, when applied to the skin (topically) once
daily during 28 days. Additionally, the safety and tolerability aspects will be evaluated in
a descriptive way, through the observation of the incidence of adverse events.